Richmond, CA, United States of America

Meidong Yang

This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: Dow Pharmaceutical Sciences, Inc.. Active years: 2011-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Meidong Yang. Retrieved from https://idiyas.com/inventor/meidong-yang-syhumriw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 3 

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 45(Granted Patents)


Company Filing History:


Years Active: 2011-2014

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations by Meidong Yang

Introduction

Meidong Yang is an accomplished inventor based in Richmond, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly in enhancing the solubility of azole drug compounds. With a total of three patents to his name, Yang's work is pivotal in improving drug formulations.

Latest Patents

Yang's latest patents focus on compositions and methods for increasing the solubility of azole drug compounds that are poorly soluble in water. His innovative approach involves the combination of any two of a polyol, a polyol ether, and a low carbon organic alcohol. This combination provides a synergistic effect on the solubility of azole compounds, such as metronidazole, in aqueous fluid.

Career Highlights

Yang is currently associated with Dow Pharmaceutical Sciences, Inc., where he continues to develop groundbreaking solutions in drug formulation. His expertise in the field has led to advancements that benefit both pharmaceutical companies and patients alike.

Collaborations

(Section skipped due to space constraints.)

Conclusion

Meidong Yang's contributions to pharmaceutical sciences through his innovative patents demonstrate his commitment to improving drug solubility and efficacy. His work continues to have a lasting impact on the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…